IL2 and neoplasm: We show that cell-mediated local cytokine (IL-2) delivery can effectively overcome immune suppression, augmenting CAR T cells to efficiently clear multiple immune-excluded tumor models (pancreatic cancer and melanoma) that are otherwise nearly completely resistant to standard CAR T cell treatment.